Ipilimumab, Vemurafenib, Dabrafenib, and Trametinib: Synergistic Competitors in the Clinical Management of BRAF Mutant Malignant Melanoma

Oncologist - United States
doi 10.1634/theoncologist.2012-0391
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma

Frontiers in Oncology
Cancer ResearchOncology
2019English

Optimizing Combination Dabrafenib and Trametinib Therapy in BRAF Mutation-Positive Advanced Melanoma Patients: Guidelines From Australian Melanoma Medical Oncologists

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2016English

Improved Overall Survival in Melanoma With Combined Dabrafenib and Trametinib

New England Journal of Medicine
Medicine
2015English

BRAF-mutant Transcriptional Subtypes Predict Outcome of Combined BRAF, MEK, and EGFR Blockade With Dabrafenib, Trametinib, and Panitumumab in Patients With Colorectal Cancer

Clinical Cancer Research
Cancer ResearchOncology
2020English

PCN87 Cost Effectiveness Evaluation of Vemurafenib, an Orphan Drug for Braf Mutant Metastatic Melanoma

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

LETTER TO THE EDITOR: Management of Vemurafenib Induced Severe Arthralgia and Pyrexia in a Patient With BRAF V600E Mutated Melanoma: First Experience With a Switch to Dabrafenib

Open Dermatology Journal
Dermatology
2015English

Synergistic Effects of Vemurafenib and Fingolimod (FTY720) in Vemurafenib‑resistant Melanoma Cell Lines

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

Vemurafenib and Trametinib Reduce Expression of CTGF and IL-8 in V600EBRAF Melanoma Cells

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2017English

Granulomatosis With Polyangiitis in a Patient Treated With Dabrafenib and Trametinib for BRAF V600E Positive Lung Adenocarcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy